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OSA compared to patients without OSA (p = 0.012). In uni-
variate analysis, A+H was associated with aortic events [haz-
ard ratio (HR) 1.09, 95% confidence interval (CI) 1.01–1.18, p = 
0.023]. Taking the interaction between BMI and A+H into ac-
count increased the HR for A+H (HR 1.75, 95% CI 1.003–3.048, 
p = 0.049). This association was no longer significant when 
other covariates were forced into the multivariate analysis. 
 Conclusions: These data suggest that aortic event-free sur-
vival may be shorter in patients with Marfan’s syndrome and 
OSA compared to patients without OSA, but more data from 
well-designed studies are needed to prove this association. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Marfan’syndrome is a connective tissue disease inher-
ited in an autosomal dominant manner. It is caused by 
mutations in the FBN1 gene localized on chromosome 
15q21, which encodes fibrillin-1, a glycoprotein that is the 
main component of microfibrils of the extracellular ma-
trix. The prevalence of Marfan’s syndrome is estimated 
to be between 1 and 3 per 10,000 individuals  [1, 2] . The 
diagnosis primarily depends on a combination of major 
and minor clinical findings defined in the ‘Ghent criteria’ 
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 Abstract 
 Background: Aortic dissection is a life-threatening manifes-
tation of Marfan’s syndrome. Preliminary evidence suggests 
that obstructive sleep apnea (OSA) is associated with aortic 
disease in Marfan’s syndrome.  Objectives: To study the ef-
fect of OSA on aortic events in Marfan’s syndrome.  Methods: 
In patients with Marfan’s syndrome, a sleep study was per-
formed at baseline and OSA was defined as  1 5 events of ap-
nea/hypopnea (A+H) per hour in bed. Operation because of 
progressive aortic dilatation and death because of aortic 
rupture were defined as ‘aortic events’. Kaplan-Meier surviv-
al analyses were used to compare event-free survival in pa-
tients with and without OSA. Cox regression models were 
used to explore the effects of covariates on event-free sur-
vival.  Results: Data from 44 patients (mean age 37.4 years, 30 
females) were available for analysis; 15 patients (34.1%) had 
OSA. The median follow-up time was 29 (interquartile range 
24–36) months. Five patients had an aortic event within the 
follow-up time. Median event-free survival was 51.6 months. 
Event-free survival was significantly shorter in patients with 
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 [3–5] . The hallmark clinical features are noted in the car-
diovascular, ocular and skeletal systems.
 Aortic root dilatation and subsequent dissection is the 
main cause of premature death in patients with Marfan’s 
syndrome. Dilatation of the aortic root can begin in 
childhood or early adulthood and increases at an unpre-
dictable rate  [6, 7] . It is a matter of debate which factors 
contribute to a rapid progression of aortic root dilatation. 
Given its impact on survival, monitoring of patients with 
Marfan’s syndrome is mainly directed toward the control 
of aortic disease.
 There is a high prevalence of obstructive sleep apnea 
(OSA) in patients with Marfan’s syndrome possibly due 
to craniofacial dysmorphism and an increased upper air-
way collapsibility  [8–10] . There is also preliminary evi-
dence for a causal link between OSA and aortic dilatation 
in patients with Marfan’s syndrome  [10–12] . Possible un-
derlying pathophysiological mechanisms are post-apnea 
reflex sympathetic activation and consequent marked in-
creases in blood pressure  [13] . In addition, large negative 
intrathoracic pressure swings, which are produced dur-
ing obstructive apneas, increase transaortic pressure and 
may therefore accelerate aortic dilatation  [14, 15] . How-
ever, there are currently no data investigating the impact 
of OSA on the risk of needing aortic root replacement 
surgery or of death in Marfan’s syndrome.
 We have addressed this uncertainty by performing a 
prospective cohort study to evaluate if OSA contributes 
to the risk of future aortic root replacement or of dying 
from aortic root dissection in patients with Marfan’s syn-
drome.
 Patients and Methods 
 Patients and Controls 
 Patients fulfilling the Ghent criteria  [3–5] for Marfan’s syn-
drome and attending their yearly clinical assessment at the Ox-
ford Radcliffe Hospitals NHS Trust were asked to participate in 
the study. Subjects were eligible if they were between 18 and 75 
years old, not pregnant, were not treated with continuous positive 
airway pressure (CPAP) and had not been operated on their aortic 
root previously. The study was approved by the Oxford Research 
Ethics Committee (REC No. 07/Q1607/6), and written informed 
consent was obtained from all participants.
 Measurements 
 The following assessments were performed at baseline:
 Anthropometrics and Blood Pressure.  Height, weight and neck 
circumference were measured. Blood pressure and heart rate were 
measured in triplicate in the sitting position with a standard dig-
ital automatic monitor (Omron Healthcare, Kyoto, Japan). The 
mean value of three readings was used for analysis.
 Sleep Studies and Questionnaire.  Subjective sleepiness was as-
sessed using the Epworth Sleepiness Scale questionnaire and 
home sleep studies were performed using the ApneaLink TM device 
(ResMed, MAP Medizin Technologie, Martinsried, Germany). 
The device records the patient’s nasal respiratory pressure signal 
and finger oximetry during sleep; it has been validated as an ac-
curate instrument to detect apnea, hypopnea and oxygen desatu-
ration  [16] . The recordings of the device were downloaded auto-
matically with dedicated software (ResMed), followed by a man-
ual scoring of apneas, hypopneas and oxygen desaturation. 
Apneas were defined as a cessation of airflow lasting  1 10 s and 
hypopneas as a reduction in airflow of at least 50% lasting  1 10 s, 
associated with a drop in oxygen saturation of  1 4%. OSA severity 
was quantified as the number events of apnea/hypopnea per hour 
of time in bed (A+H). The minimal criterion for an acceptable 
sleep study duration was 5 h (with nasal respiratory pressure and 
pulse-oximetry signal).
 Aortic Root Diameter Measurements.  In all patients with Mar-
fan’s syndrome, echocardiography was performed by the same 
cardiac ultrasound technician, who was not involved in the anal-
ysis of the data. Aortic root diameter was measured in parasternal 
long-axis view at end-diastole (peak of R wave on electrocardio-
gram) and at end-systole (T wave on electrocardiogram) by two-
dimensional, M-mode echocardiography with a commercially 
available cardiac ultrasound system (Sonos 4500; Philips Health-
care, Guilford, UK), using a 3.5-MHz transducer. The diameter 
of the aorta was assessed at several levels: at the left-ventricular 
outflow tract, sinuses of Valsalva, supra-aortic ridge and at the 
proximal ascending aorta, 1–2 cm above the supra-aortic ridge, as 
described previously  [17] . The maximal diameter of the aortic 
root from these four assessments and the maximal diameter cor-
rected for body surface area were calculated  [17] .
 Follow-Up Assessments.  Follow-up assessments were sched-
uled according to routine clinical practice, usually at 1-year inter-
vals, and included a medical history, measurement of anthropo-
metrics as well as echocardiography.
 Outcome. Operation because of progression of aortic root di-
latation and death because of aortic root dissection/rupture were 
defined as an ‘aortic event’. Survival time without an aortic event 
was defined as the primary outcome.
 Data Analysis 
 Data are expressed as means (SD) unless otherwise stated. Sta-
tistical analyses were performed with STATA, College Station, 
Tex., USA (version 11.1 for Windows). In order to define OSA, a 
conventional threshold level of A+H  1 5/h was used. Differences 
in baseline characteristics between patients with and without 
OSA were assessed by independent t tests. Kaplan-Meier survival 
analyses were used to allow for variable follow-up times and to 
estimate the proportion of patients without an aortic event. The 
log-rank test was used to compare rates of aortic events between 
patients with and without OSA. Univariate Cox regression was 
applied to investigate the association between patient character-
istics and survival without an aortic event. To further evaluate the 
independent association between aortic events and A+H, we used 
multivariable Cox regression modeling, including age, gender, 
baseline aortic diameter, body mass index (BMI), systolic blood 
pressure, antihypertensive medication and A+H as potential con-
founding covariates. A two-sided p  ! 0.05 was considered to be 
statistically significant.
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 Results 
 Study Profile and Characteristics of the Participants 
 Figure 1 shows the study profile. Patients with Marfan’s 
syndrome were recruited from 41 unrelated families (no 
apparent relationships in their pedigree). Follow-up data 
from 44 patients with Ghent criteria-positive Marfan’s syn-
drome and without previous operation on their aorta were 
available for analysis. Fifteen patients (34.1%) fulfilled the 
criteria of having OSA. Patients with OSA were older, had 
a higher BMI and a larger neck circumference than pa-
tients without OSA ( table 1 ). The two groups were similar 
regarding their blood pressure, heart rate and baseline aor-
tic diameter corrected for body surface area ( table 1 ).
 Event-Free Survival 
 The median (interquartile range) follow-up time after 
the baseline assessment was 29 (24–36) months. Within 
the follow-up period, 4 patients had aortic valve-sparing 
aortic root replacement and 1 patient died of aortic rup-
ture. Median event-free survival was 51.6 months. As all 
patients with aortic events had OSA, event-free survival 
was significantly shorter in patients with OSA compared 
to patients without OSA (p = 0.012;  fig. 2 ).
83 patients fulfilling
Ghent criteria
49 patients with Marfan’s
syndrome entered the study
231 patients with possible 
Marfan’s syndrome screened
Data of 44 patients analyzed
5 patients lost to follow-up
34 did not enter the study
 • 12 did not attend clinic
 • 7 did not consent
 • 3 did not agree to sleep study
 • 12 patients had previous
  aortic surgery 
 Fig. 1. Study profile. 
Table 1.  Patient characteristics at baseline
Patients
with OSA
(n = 15)
Patients
without OSA
(n = 29)
p value
Age, years 44.0 (14.0) 33.9 (13.4) 0.025
Males/females 8/7 6/23 0.028
BMI 30.0 (7.0) 22.6 (3.9) <0.001
Neck circumference, cm 39.2 (2.7) 34.7 (3.1) <0.001
Systolic blood pressure, mm Hg 124.9 (13.7) 121.4 (14.7) 0.449
Diastolic blood pressure, mm Hg 78.6 (11.9) 77.2 (12.0) 0.723
Heart rate, beats/min 61.6 (8.5) 64.1 (11.7) 0.466
Antihypertensive medication, % 80.0 72.4 0.582
Aortic diameter, cm 4.3 (0.4) 3.7 (0.6) <0.001
Aortic diameter/BSA 2.0 (0.3) 2.0 (0.3) 0.747
Aortic expansion rate, cm/year 0.22 (0.68) 0.07 (0.21) 0.276
A+H, events/h 18.0 (11.3) 2.4 (1.5) <0.001
ODI, n/h 9.8 (7.9) 2.1 (2.5) <0.001
Snoring, events/h 88.6 (107.5) 26.8 (33.8) 0.008
Time in bed, min 408 (65) 447 (81) 0.101
ESS 7.6 (3.9) 7.8 (5.2) 0.899
V alues are means (SD) were applicable. BSA = Body surface area; ODI = oxygen desaturation index; ESS = Epworth Sleepiness Score.
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 In univariate analysis, higher A+H and higher aortic 
diameter at baseline were both associated with a signifi-
cantly increased hazard ratio (HR) for aortic events ( ta-
ble 2 ).
 Because being overweight is a major independent risk 
factor for OSA, we further investigated a potential modi-
fying effect of BMI on the risk of aortic events due to an 
increased A+H by introducing an interaction term (i.e. 
BMI  ! A+H) in a bivariate Cox regression model (i.e. 
independent variables were A+H, BMI and its interaction 
term). Taking into account an interaction between BMI 
and A+H resulted in a considerable increase in HR for 
A+H ( table 3 ). Further controlling for all potential con-
founders, regardless of whether significant in univariate 
analysis, revealed an unchanged HR for A+H; however, 
the association between aortic events and OSA did not 
remain statistically significant ( table 3 ).
 Discussion 
 This is the first prospective cohort study providing 
data on the relationship between OSA and aortic events 
in patients with Marfan’s syndrome. We found that pa-
tients with OSA had a significantly shorter event-free 
survival compared to patients without OSA, which sug-
gests that OSA may be an important risk factor for aortic 
events. If this finding is confirmed in larger cohorts, then 
patients with Marfan’s syndrome should be evaluated 
and possibly treated for OSA in order to reduce the risk 
of aortic complications.
 Aortic dilatation and associated aortic dissection and 
rupture are still the main cause of morbidity and mor-
tality in patients with Marfan’s syndrome  [18] . Thus, the 
prevention of aortic complications is of major concern 
for physicians caring for patients with Marfan’s syn-
drome. As it is largely unknown which factors contrib-
ute to a rapid progression of aortic root dilatation in 
these patients, the prevention of aortic dissection and 
rupture currently rests on lifestyle advice, pharmacolog-
ical treatments (e.g.   -blockers) and ultimately prophy-
lactic aortic surgery  [18–20] . Identification of any treat-
able risk factor for aortic complications in patients with 
Marfan’s syndrome is thus of major scientific and clini-
cal interest.
 There is some preliminary evidence that OSA may be 
a risk factor for the development and progression of aor-
tic aneurysms in patients with and without Marfan’s syn-
drome  [10–12, 21–23] . Kohler et al.  [10] recently reported 
that the severity of OSA in patients with Marfan’s syn-
Table 2.  Univariate analysis
HR SE p value 95% CI
Age 1.05 0.04 0.192 0.98–1.13
Gender (male = reference) 5.53 6.41 0.140 0.57–53.64
Baseline aortic diameter 11.12 12.31 0.029 1.27–97.31
BMI 1.07 0.07 0.281 0.94–1.22
Systolic blood pressure 1.05 0.04 0.202 0.97–1.14
A+H 1.09 0.04 0.023 1.01–1.18
Antihypertensive
medication 0.34 0.34 0.284 0.05–2.44
Table 3.  Multivariate analysis
A+H HR SE p value 95% CI
Model 1 1.12 0.06 0.028 1.01–1.24
Model 2 1.75 0.50 0.049 1.00–3.05
Model 3 2.04 1.25 0.246 0.61–6.80
M odel 1 was controlled for BMI only, model 2 for BMI and an 
interaction term (BMI ! A+H), and model 3 was controlled for 
BMI, BMI ! A+H, age, gender, systolic blood pressure, antihy-
pertensive medication and baseline aortic diameter.
0
0.2
0.4
0.6
0.8
1.0
C
um
ul
at
iv
e 
p
ro
p
or
ti
on
 w
it
h
ou
t 
ev
en
t
0 6 12 18 24 30 36 42 48
Time (months)
 Fig. 2. Kaplan-Meier plot showing the proportion of patients 
without aortic events in subjects with OSA ( ––––– ) and those with-
out OSA (· · · · ·). Event-free survival was significantly shorter in 
patients with OSA compared to patients without OSA (p = 0.012). 
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drome is associated with an increased aortic root diam-
eter and patients with OSA have a larger aortic root than 
patients without OSA. In the current study, we found that 
patients with Marfan’s syndrome and OSA had a signifi-
cantly shorter aortic event-free survival than patients 
without OSA. In univariate analysis, the only variables 
statistically significantly associated with a higher risk for 
aortic events were baseline aortic diameter and the sever-
ity of OSA ( table 2 ). The HR of 1.09 for each additional 
A+H event per hour suggests that a patient with an A+H 
of 10 events/h has about a two times higher risk of need-
ing aortic replacement surgery or of dying from aortic 
rupture for example.
 Obesity is the most important factor in the pathogen-
esis of OSA, thus BMI and A+H are expected to be strong-
ly interrelated. By adding an interaction term for BMI 
and A+H to the multivariate analysis, the HR for A+H 
increased considerably to 1.75, suggesting that particu-
larly Marfan patients who are overweight and have OSA 
may be at high risk of having aortic complications. This 
is supported by the fact that all 5 patients with aortic 
events had OSA, and 4 of the 5 patients also had BMI 
above the median BMI of the cohort (data not shown). 
Although HR (1.76) was unaffected by additional correc-
tion for age, gender, baseline aortic diameter and blood 
pressure in multivariate analysis, the association between 
A+H and aortic events did not remain statistically sig-
nificant. This is most likely due to the relatively small 
number of patients studied given the limited number of 
aortic events observed. Thus, further studies investigat-
ing the effect of OSA on aortic events in larger cohorts of 
Marfan patients are needed.
 The findings of the current study suggest that obese 
patients with Marfan’s syndrome should perhaps be eval-
uated for OSA and may benefit from weight reduction or 
CPAP. This is corroborated by the findings of two case 
reports in which treatment of OSA with CPAP was asso-
ciated with attenuation of aortic root dilatation in 3 pa-
tients with Marfan’s syndrome  [11, 12] . However, more 
data from interventional studies investigating the effect 
of CPAP on aortic dilatation and aortic events are needed 
before CPAP therapy can be recommended as a therapy 
to improve outcome in patients with Marfan’s syndrome 
and OSA.
 To date, the underlying mechanisms through which 
OSA may promote aortic dilatation are not clear. OSA 
has been shown to be associated with increased diurnal 
blood pressure as well as with recurrent pronounced 
surges in blood pressure during apneic events  [24] , which 
is the proposed main risk factor for aortic dilatation and 
dissection  [25] . In addition, obstructive apneas are asso-
ciated with repeated inspiratory effort against the col-
lapsed pharynx causing recurrent large negative intra-
thoracic pressures (sometimes as low as –80 mm Hg) and 
thereby producing radial forces on intrathoracic struc-
tures including the ascending aorta  [26] . This hypothesis 
is supported by the findings of Peters et al.  [27, 28] who 
reported increased aortic diameters during obstructive 
apnea in an animal model. In healthy humans, experi-
mentally simulated obstructive A+H has also been shown 
to lead to an acute increase in proximal aortic diameter 
 [15] . Furthermore, Sampol et al.  [21] found that non-
Marfan patients with dissection of the thoracic aorta had 
a higher index of A+H than well-matched hypertensive 
control subjects without dissection, suggesting that OSA 
may be a risk factor for aortic dissection. Thus, the cur-
rent body of evidence suggests that intrathoracic pres-
sure swings and acute blood pressure rises, rather than 
intermittent hypoxia, may be the most important mech-
anisms underpinning the association between OSA and 
thoracic aortic disease. This is also supported by our pre-
vious work on OSA and aortic dilatation in patients with 
Marfan’s syndrome where we found a much stronger 
correlation between apneas and aortic root diameter 
than between oxygen indices and aortic root diameter 
 [10] .
 The current study has some limitations which need to 
be mentioned. We did not use full polysomnography, 
which would have been the gold standard for quantifica-
tion of sleep-disordered breathing; however, this is very 
unlikely to have biased outcome in any way. The number 
of patients with Marfan’s syndrome in this study without 
previous aortic root replacement is relatively small, given 
the number of aortic events observed during the follow-
up period. Thus, further prospective cohort studies in-
cluding a larger number of patients with Marfan’s syn-
drome will be needed to corroborate our findings. How-
ever, as Marfan’s syndrome is a rare disorder and the 
existing cohorts of these patients tend to be small, such a 
prospective study would possibly need a multicenter de-
sign. Finally, data from interventional studies looking at 
the effect of CPAP on aortic dilatation and aortic events 
are required before a causal relationship between OSA 
and aortic disease can be established.
 In conclusion, we have shown that in a cohort of pa-
tients with Marfan’s syndrome having OSA may be asso-
ciated with a shorter aortic event-free survival compared 
to patients without OSA. The risk for aortic events seems 
to be primarily elevated in patients with Marfan’s syn-
drome who are overweight and have OSA. These findings 
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suggest that overweight patients with Marfan’s syndrome 
should be evaluated and possibly treated for OSA in order 
to reduce the risk of aortic complications. However, data 
from randomized interventional trials are needed to def-
initely prove this relationship. 
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